UVLrx Therapeutics

Oldsmar, United States Founded: 2011 • Age: 15 yrs
Offers a light therapy-based treatment system for therapeutic applications.

About UVLrx Therapeutics

UVLrx Therapeutics is a company based in Oldsmar (United States) founded in 2011 by Michael Harter. It operates as a B2B. UVLrx Therapeutics has raised $1.05 million across 6 funding rounds. UVLrx Therapeutics operates in a competitive market with competitors including CareWear, THOR Photomedicine, Solio Therapy, Anodyne Therapy and Bright Photomedicine, among others.

  • Headquarter Oldsmar, United States
  • Founders Michael Harter
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.05 M (USD)

    in 6 rounds

  • Latest Funding Round
    $40 K (USD), Seed

    May 23, 2018

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of UVLrx Therapeutics

UVLrx Therapeutics has successfully raised a total of $1.05M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $40 thousand completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Seed — $40,000
  • First Round

    (24 Jan 2014)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2018 Amount Seed - UVLrx Therapeutics Valuation

investors

Nov, 2016 Amount Seed - UVLrx Therapeutics Valuation

investors

Jul, 2015 Amount Seed - UVLrx Therapeutics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by UVLrx Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - UVLrx Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Uvlrx Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of UVLrx Therapeutics

UVLrx Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CareWear, THOR Photomedicine, Solio Therapy, Anodyne Therapy and Bright Photomedicine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of light patch for pain relief and injury recovery for athletes
domain founded_year HQ Location
Devices for Low Level Light therapy for pain and inflammation reduction
domain founded_year HQ Location
Provides light therapy devices for chronic pain relief and injury treatment.
domain founded_year HQ Location
Provides infrared light therapy devices for non-invasive pain management and relief.
domain founded_year HQ Location
Wearable phototherapy devices for pain management are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Uvlrx Therapeutics

Frequently Asked Questions about UVLrx Therapeutics

When was UVLrx Therapeutics founded?

UVLrx Therapeutics was founded in 2011 and raised its 1st funding round 3 years after it was founded.

Where is UVLrx Therapeutics located?

UVLrx Therapeutics is headquartered in Oldsmar, United States. It is registered at Oldsmar, Florida, United States.

Who is the current CEO of UVLrx Therapeutics?

Michael Harter is the current CEO of UVLrx Therapeutics. They have also founded this company.

Is UVLrx Therapeutics a funded company?

UVLrx Therapeutics is a funded company, having raised a total of $1.05M across 6 funding rounds to date. The company's 1st funding round was a Seed of $25.2K, raised on Jan 24, 2014.

What does UVLrx Therapeutics do?

UVLrx Therapeutics offers a light therapy-based treatment system for therapeutic applications through providing healthcare solutions, therapeutics, developing medical devices, and light therapy. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Who are the top competitors of UVLrx Therapeutics?

UVLrx Therapeutics's top competitors include THOR Photomedicine, Bright Photomedicine and CareWear.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available